| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | — | +50.5% |
| Cost of Revenue | $3.6M | — | -27.3% |
| Gross Profit | $11.6M | — | +124.4% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $4.3M | — | -4.4% |
| Operating Income | $6.9M | — | +1980.6% |
| Pre-tax Income | $6.9M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -76.7% | -84.7% |
| Accounts Receivable | $359K | +90.5% | +768.7% |
| Current Assets | $68.2M | +22.4% | +72.9% |
| Total Assets | $72.8M | +14.2% | +58.8% |
| Current Liabilities | $38.1M | -6.7% | +29.7% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $35.8M | — | +9418.9% |
| Investing Cash Flow | $4.3M | — | +425.0% |
| Financing Cash Flow | -$25.2M | — | -2587.2% |
| +2183.5% |
| Net Income | $6.9M | — | +2181.5% |
| EPS (Basic) | $0.02 | — | — |
| EPS (Diluted) | $0.02 | — | — |
| $38.9M |
| -5.9% |
| +28.9% |
| Stockholders' Equity | $33.8M | +51.3% | +116.4% |